ANTIHYPERTENSIVE EFFICACY OF FIXED COMBINATION AZILSARTAN MEDOXOMIL/CHLORTHALIDONE IN PATIENTS WITH UNCONTROLLED ARTERIAL HYPERTENSION

被引:0
|
作者
Kobalava, Zh. D. [1 ]
Villevalde, S. V. [1 ]
Kulakov, V. V. [1 ]
机构
[1] RUDN Univ, Peoples Friendship Univ Russia, Moscow, Russia
关键词
azilsartan medoxomil; chlorthalidone; ambulatory blood pressure monitoring; efficacy; safety; BLOOD-PRESSURE; MEDOXOMIL; CHLORTHALIDONE; HYDROCHLOROTHIAZIDE; MANAGEMENT; VALSARTAN;
D O I
10.10087/cardio.2017.11.10049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To study effects of a fixed azilsartan medoxomil/chlorthalidone combination (Edarbi Clo) on clinical, ambulatory and central blood pressure (BP) in patients with uncontrolled arterial hypertension (AH)). Materials and methods. Patients (n=25) with uncontrolled AH were given fixed azilsartan medoxomil/chlorthalidone combination (40/12.5 mg/day) for 4 weeks. After 4 weeks, in patients who did not achieve target BP levels the dose was increased up to 40/25 mg/day. Duration of the study was 12 weeks. Results. After 12 weeks of treatment 88% of patients achieved target clinical BP (< 140/90 mm Hg without diabetes, < 140/85 mm Hg with diabetes). According to 24-hour blood pressure monitoring (ABPM) decline of mean BP was 19.3/11.1 mm Hg, of mean daytime peripheral BP - 20.1/11.4 mm Hg, of mean nocturnal peripheral BP - 19.5/9.1 mm Hg, of central systolic (S), diastolic and pulse BP - 15.8, 10.1, 6.6 mm Hg, respectively. Target values of mean 24-hour BP were achieved in 40% of patients. Improvement of ABPM parameters led to normalization of the daily systolic BP index, associated with increase of the portion of "dippers" (from 60 to 64%) and reduction of that of "night-pickers" at the account of their transition into "non-dipper" and "dipper" categories. There were no adverse events either causing discontinuation after the first dose or serious. Conclusion. In patients with uncontrolled AP with/without diabetes therapy with fixed- azilsartan medoxomil/chlorthalidone combination was accompanied by pronounced antihypertensive effect (lowering of clinical, daily peripheral BP, improvement of the daily SBP profile). For the first time, the effectiveness of azilsartan medoxomil/chlorthalidone combination was demonstrated in relation to the central systolic, diastolic and pulse BP. Significant changes of parameters of carbohydrate or lipid metabolism, adverse events leading to drug discontinuation were not registered.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 50 条
  • [31] Pharmacokinetic-pharmacodynamic modeling of the antihypertensive interaction between azilsartan medoxomil and chlorthalidone in spontaneously hypertensive rats
    Santosh Kumar Puttrevu
    Rachumallu Ramakrishna
    Manisha Bhateria
    Moon Jain
    Kashif Hanif
    Rabi Sankar Bhatta
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2017, 390 : 457 - 470
  • [32] Adherence to antihypertensive therapy in patients with uncontrolled arterial hypertension
    Dotsenko, S. Y.
    ZAPOROZHYE MEDICAL JOURNAL, 2013, (02) : 14 - 17
  • [33] Efficacy and safety of olmesartan medoxomil/amlodipine fixed-dose combination for hypertensive patients uncontrolled with monotherapy
    Jun-Ren Zhu
    Shu-Yang Zhang
    Ping-Jin Gao
    Archives of Pharmacal Research, 2014, 37 : 1588 - 1598
  • [34] Efficacy and safety of olmesartan medoxomil/amlodipine fixed-dose combination for hypertensive patients uncontrolled with monotherapy
    Zhu, Jun-Ren
    Zhang, Shu-Yang
    Gao, Ping-Jin
    ARCHIVES OF PHARMACAL RESEARCH, 2014, 37 (12) : 1588 - 1598
  • [35] Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy
    Hsueh, Willa A.
    Shojaee, Ali
    Maa, Jen-Fue
    Neutel, Joel M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (11) : 1809 - 1818
  • [36] Long-term efficacy and tolerability of azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide in chronic kidney disease
    Bakris, George L.
    Zhao, Lin
    Kupfer, Stuart
    Juhasz, Attila
    Hisada, Michie
    Lloyd, Eric
    Oparil, Suzanne
    JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (04): : 694 - 702
  • [37] Hronotherapy Aspects of Efficiency Azilsartan Medoxomil in Combination Therapy in Patients With Hypertension and Metabolic Syndrome
    Skibitskiy, V. V.
    Fendrikova, A. V.
    Sirotenko, D. V.
    Skibitskiy, A. V.
    KARDIOLOGIYA, 2016, 56 (10) : 35 - 40
  • [38] Comparison of long-term safety of fixed-dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide
    Neutel, Joel M.
    Cushman, William C.
    Lloyd, Eric
    Barger, Bruce
    Handley, Alison
    JOURNAL OF CLINICAL HYPERTENSION, 2017, 19 (09): : 874 - 883
  • [39] ECONOMY OF ANTIANGINAL AND ANTIHYPERTENSIVE EFFICACY OF THE FIXED COMBINATION OF BISOPROLOL/AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE
    Tarlovskaya, E.
    Malchikova, S.
    Skibitskyi, V.
    Fendrikova, A.
    Skibitskyi, A.
    Sirotenko, D.
    JOURNAL OF HYPERTENSION, 2015, 33 : E328 - E329
  • [40] CHLORTHALIDONE IN UNCONTROLLED ARTERIAL-HYPERTENSION, A MULTICENTER TRIAL
    LEAL, FGD
    INVESTIGACION MEDICA INTERNACIONAL, 1983, 10 (02): : 173 - 176